Chronic Lymphocytic Leukemia Clinical Trial
Efficacy and Safety of Idelalisib in Combination With Ofatumumab for Previously Treated Chronic Lymphocytic Leukemia
Summary
The primary objective of this study is to evaluate the effect of the addition of idelalisib to ofatumumab on progression-free survival (PFS) in participants with previously treated leukemia-cll/" >chronic lymphocytic leukemia (CLL).
Eligibility Criteria
Key Inclusion Criteria:
Adults with previously treated recurrent CLL who have measurable lymphadenopathy
Require therapy for CLL
Have experienced CLL progression < 24 months since the completion of the last prior therapy
Have disease that is not refractory to ofatumumab
Note: Other protocol defined Inclusion/Exclusion criteria may apply.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 78 Locations for this study
Duarte California, 91010, United States
Fresno California, 93720, United States
San Diego California, 92120, United States
San Luis Obispo California, 93401, United States
Stanford California, 94305, United States
Vallejo California, 94589, United States
Denver Colorado, 80205, United States
Grand Junction Colorado, 81501, United States
Jacksonville Florida, 32256, United States
Augusta Georgia, 30912, United States
Mount Sterling Kentucky, 40353, United States
Bethesda Maryland, 20817, United States
Boston Massachusetts, 02215, United States
Saint Louis Missouri, 63110, United States
Las Vegas Nevada, 89169, United States
New York New York, 10065, United States
Cincinnati Ohio, 45242, United States
Columbus Ohio, 43202, United States
Portland Oregon, 97239, United States
Greenville South Carolina, 29601, United States
Chattanooga Tennessee, 37404, United States
Nashville Tennessee, 37203, United States
Salt Lake City Utah, 84106, United States
Tacoma Washington, 98405, United States
Kogarah New South Wales, 2217, Australia
Randwick New South Wales, 2031, Australia
Westmead New South Wales, 2145, Australia
Herston Queensland, 4029, Australia
Milton Queensland, 4064, Australia
Ashford South Australia, 5035, Australia
Box Hill Victoria, 3128, Australia
Melbourne Victoria, 3199, Australia
Woodville , 5011, Australia
Antwerpen , 2060, Belgium
Brussels , 1200, Belgium
Ghent , 9000, Belgium
Leuven , 3000, Belgium
Calgary Alberta, T2N 2, Canada
Edmonton Alberta, T6G 1, Canada
Winnipeg Manitoba, R3E 0, Canada
Sudbury Ontario, P3E 5, Canada
Montréal Quebec, H1T 2, Canada
Rimouski Quebec, G5L 5, Canada
Regina Saskatchewan, S4T 1, Canada
Winnipeg , R3E 0, Canada
Aalborg , 9100, Denmark
Ã…rhus , 8000, Denmark
Pessac Cedex Aquitaine, 33604, France
Paris Cedex 10 Ile-de-france, 75010, France
Perpignan Languedoc-Roussillon, 66046, France
Vandoeuvre Limousin, Lorraine, 54511, France
Toulouse Cedex Midi-pyrenees, 31059, France
Auvergne , 63000, France
Ile-de-france , 93009, France
Cork , , Ireland
Dublin , 8, Ireland
Kraków Malopolskie, 31-50, Poland
Slupsk Pomorskie, 76-20, Poland
Brzozow , 36-20, Poland
Lódz , 93-51, Poland
Warszawa , 02-50, Poland
Wroclaw , 50-36, Poland
Barcelona , 08025, Spain
Barcelona , 08035, Spain
Madrid , 28006, Spain
Madrid , 28041, Spain
Madrid , 28222, Spain
Murcia , 30008, Spain
Luleå , 971 8, Sweden
Stockholm , 171 6, Sweden
Stockholm , 171 7, Sweden
Birmingham England, B9 5S, United Kingdom
Dartford England, DA2 8, United Kingdom
Guildford England, GU2 7, United Kingdom
Manchester England, M20 4, United Kingdom
Norwich Norfolk, NR4 7, United Kingdom
Leeds , LS9 7, United Kingdom
London , NW1 2, United Kingdom
London , WC1E , United Kingdom
Oxford , OX3 7, United Kingdom
How clear is this clinincal trial information?

Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.